Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Patients who have no residual invasive cancer following neoadjuvant chemotherapy for breast carcinoma have a better overall survival than those with residual disease. Many classification systems assessing pathological response to neoadjuvant chemotherapy include residual ductal carcinoma in situ (DC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jones, R L, Lakhani, S R, Ring, A E, Ashley, S, Walsh, G, Smith, I E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2006
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361141/
https://ncbi.nlm.nih.gov/pubmed/16421590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602950
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak